GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 259.80
Bid: 259.60
Ask: 259.80
Change: 0.80 (0.31%)
Spread: 0.20 (0.077%)
Open: 259.00
High: 260.80
Low: 258.20
Prev. Close: 259.00
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

15 Mar 2022 07:00

RNS Number : 7418E
Man Group plc
15 March 2022
 

 

SECOND TRANCHE OF THE $250 MILLION SHARE BUYBACK PROGRAMME

 

On 8 December 2021, Man Group plc (the "Company") announced its intention to buy back shares up to a value of $250 million (the "Share Buyback Programme") with a first tranche of up to $125 million (the "First Tranche"). The First Tranche began on 8 December 2021 and is expected to complete in the coming days. The Company now announces that it will commence the next tranche of the Share Buyback Programme of up to $125 million (the "Second Tranche") following the completion of the First Tranche.

 

The Company has extended its original irrevocable, non-discretionary agreement with J.P. Morgan Securities plc to repurchase, on its behalf, the Company's shares (as announced on 8 December 2021) by increasing the maximum value from $125 million to $250 million in order to cover the Second Tranche. No other amendments have been made to the terms of the original irrevocable, non-discretionary agreement. Share purchases will take place in open market transactions and may be made from time to time depending on market conditions, share price, trading volume and other factors. Share purchases can take place up to 7 December 2022, and may continue during any closed period to which the Company is subject.

 

Further details of the Share Buyback Programme are contained in the announcement entitled 'Share Buyback Programme of up to $250 million', which was released on 8 December 2021.

 

Enquiries

Karan Shirgaokar

Director, Investor Relations

+44 (0)20 7144 1434

investor.relations@man.com 

 

Georgiana Brunner

Head of Communications

+44 (0)20 7144 1000

media@man.com

 

 Neil DoyleFTI Consulting

+44 (0)777 1978 220

Man@FTIConsulting.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGPUMGWUPPGRC
Date   Source Headline
31st Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Stonebridge Biopharma plc
30th Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
27th Aug 20215:41 pmRNSTransaction in Own Shares
27th Aug 20218:20 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
26th Aug 20215:35 pmRNSTransaction in Own Shares
26th Aug 202110:18 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 20215:47 pmRNSTransaction in Own Shares
25th Aug 202112:59 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 202112:54 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
24th Aug 20215:45 pmRNSTransaction in Own Shares
24th Aug 202112:21 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
24th Aug 202112:17 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
23rd Aug 20216:24 pmRNSTransaction in Own Shares
23rd Aug 20211:49 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
23rd Aug 20211:47 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20215:53 pmRNSTransaction in Own Shares
20th Aug 20218:57 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20218:56 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 20215:55 pmRNSTransaction in Own Shares
19th Aug 202112:27 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 202112:23 pmGNWMan Group PLC : Form 8.3 - Vectura Group plc
19th Aug 20219:00 amRNSInterim Dividend Conversion Rate
18th Aug 20215:25 pmRNSTransaction in Own Shares
18th Aug 20218:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
17th Aug 20216:03 pmRNSTransaction in Own Shares
17th Aug 202110:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
16th Aug 20215:59 pmRNSTransaction in Own Shares
16th Aug 202112:05 pmGNWMan Group PLC : Form 8.3 - Strongbridge biopharma plc
13th Aug 20215:20 pmRNSTransaction in Own Shares
13th Aug 202111:05 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
12th Aug 20215:57 pmRNSTransaction in Own Shares
12th Aug 202111:23 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20215:45 pmRNSTransaction in Own Shares
11th Aug 202110:36 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20217:00 amRNSTransaction in Own Shares
10th Aug 202111:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
10th Aug 20217:00 amRNSShare buyback programme of up to $100 million
9th Aug 20219:41 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
9th Aug 20219:39 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
6th Aug 20219:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:30 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:26 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
4th Aug 20212:12 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
4th Aug 20212:09 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
3rd Aug 202112:28 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
3rd Aug 202112:25 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Aug 20211:42 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
2nd Aug 20211:38 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Aug 20211:34 pmGNWMan Group PLC : Form 8.3 - John Laing Group plc
2nd Aug 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.